lebrikizumab   Click here for help

GtoPdb Ligand ID: 7684

Synonyms: Ebglyss® | lebrikizumab-lbkz | MILR1444A | RG3637 | TNX-650
Approved drug Immunopharmacology Ligand
lebrikizumab is an approved drug (EMA (2023), FDA (2024))
Compound class: Antibody
Comment: Lebrikizumab is a an anti-IL-13 monoclonal antibody.
Peptide sequence and structural information for this antibody are available from its IMGT/mAb-db record.
Classification Click here for help
Compound class Antibody
Approved drug? Yes. EMA (2023)
International Nonproprietary Names Click here for help
INN number INN
9165 lebrikizumab
Synonyms Click here for help
Ebglyss® | lebrikizumab-lbkz | MILR1444A | RG3637 | TNX-650
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 325
Other databases
GtoPdb PubChem SID 223366019
Search PubMed clinical trials lebrikizumab
Search PubMed titles lebrikizumab
Search PubMed titles/abstracts lebrikizumab
Wikipedia Lebrikizumab